Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr-Jun;55(2):140-3.
doi: 10.4103/0019-5154.62743.

Nondermatophytic moulds as a causative agent of onychomycosis in tehran

Affiliations

Nondermatophytic moulds as a causative agent of onychomycosis in tehran

Shahindokht Bassiri-Jahromi et al. Indian J Dermatol. 2010 Apr-Jun.

Abstract

Background: In the last few years the number of cases of nondermatophytic onychomycosis has greatly increased.

Aim: To evaluate the incidence, the clinic characteristics, and predisposing factors of nondermatophytic onychomycosis.

Materials and methods: All collected specimens were analyzed by direct microscopy and culture. Microscopic examination of these specimens was carried out in potassium hydroxide solution (20%) with dimethyl sulfoxide (4%). These specimens were cultured on sabouraud's glucose agar with chloramphenicol and sabouraud's glucose agar with chloramphenicol and cycloheximide. Cultures were incubated at 25 degrees C for up to 28 days and checked twice weekly for growth.

Results: Nondermatophytic onychomycosis were 11.5% of all onychomycosis. We found that Aspergillus spp. were the more responsible etiologic agents of nondermatophytic onychomycosis, resulting in a total of 28 patients (59.6%). In our study other causative agents were Acremonium spp. (17%), Fusarium spp. (12.7%), Geotrichum spp. (4.2%), Trichosporun spp., (4.2%) and Scopulariopsis spp (2.1%). In our patients moulds onychomycosis developed mainly in toenails (74.5%).

Conclusion: Knowing the exact pathogen is important and has implications in therapy and prognosis.

Keywords: Fungal infections; Iran; mould; onychomycosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

References

    1. Andre J, Achten G. Onychomycosis. Int J Dermatol. 1987;26:481–90. - PubMed
    1. Ellis DH, Marley JE, Watson AB, Williams TG. Significance of non-dermatophyte moulds and yeasts in onychomycosis. Dermatology. 1997;194:40–2. - PubMed
    1. Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey. Br J Dermatol. 1992;126:23–7. - PubMed
    1. Rippon JW. Medical mycology. 3rd ed. Philadelphia, USA: W.B. Saunders Co.; 1988. pp. 169–275.
    1. Koskuakis CE, Scher RK, Ackerman AB. Biopsis of nails. What histplogic findings distinguish onychomycosis from psoriasi? Am J Dermatopathol. 1983;5:501–3. - PubMed